Your browser doesn't support javascript.
loading
Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets.
Norris, Peter A A; Tawhidi, Zoya; Sachs, Ulrich J; Cserti-Gazdewich, Christine M; Lin, Yulia; Callum, Jeannie; Gil Gonzalez, Lazaro; Shan, Yuexin; Branch, Donald R; Lazarus, Alan H.
Afiliação
  • Norris PAA; Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada.
  • Tawhidi Z; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Sachs UJ; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
  • Cserti-Gazdewich CM; Toronto Platelet Immunobiology Group, Toronto, ON, Canada.
  • Lin Y; Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada.
  • Callum J; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Gil Gonzalez L; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
  • Shan Y; Toronto Platelet Immunobiology Group, Toronto, ON, Canada.
  • Branch DR; Institute for Clinical Immunology, Transfusion Medicine, and Haemostasis, Justus Liebig University, Giessen, Germany.
  • Lazarus AH; Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany.
Blood Adv ; 7(14): 3561-3572, 2023 07 25.
Article em En | MEDLINE | ID: mdl-37042934
Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor-triggered macrophage phagocytosis of platelets using specimens from patients with ITP. Here, we assessed sera from a cohort of 24 patients with ITP for the capacity to trigger macrophage phagocytosis of normal donor platelets and characterized the contribution of humoral factors to phagocytosis. Sera that produced a phagocytosis magnitude greater than a normal human serum mean + 2 standard deviations were considered phagocytosis-positive. Overall, 42% (8/19) of MHC I alloantibody-negative ITP sera were phagocytosis-positive. The indirect monoclonal antibody immobilization of platelet antigens assay was used to detect immunoglobulin G (IgG) autoantibodies to glycoproteins (GP)IIb/IIIa, GPIb/IX, and GPIa/IIa. Autoantibody-positive sera triggered a higher mean magnitude of phagocytosis than autoantibody-negative sera. Phagocytosis correlated inversely with platelet counts among autoantibody-positive patients but not among autoantibody-negative patients. Select phagocytosis-positive sera were separated into IgG-purified and -depleted fractions via protein G and reassessed for phagocytosis. Phagocytosis was largely retained in the purified IgG fractions. In addition, we assessed serum concentrations of C-reactive protein, serum amyloid P, and pentraxin 3 as potential phagocytosis modulators. Pentraxin 3 concentrations correlated inversely with platelet counts among patients positive for autoantibodies. Taken together, sera from approximately half of the patients with ITP studied triggered macrophage phagocytosis of platelets beyond a normal level. An important role for antiplatelet autoantibodies in phagocytosis is supported; a role for pentraxins such as pentraxin 3 may be suggested.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Púrpura Trombocitopênica Idiopática Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article